How Old Do You Have to Be to Get Shingles? Risk by Age

There is no minimum age for shingles. Anyone who has had chickenpox, or even the chickenpox vaccine, can develop shingles at any point afterward, including in childhood. That said, the risk is heavily skewed toward older adults: rates climb sharply starting around age 50, and the highest incidence falls in the 70-to-79 age range. The real question isn’t just when you can get shingles, but when you’re most likely to, how dangerous it becomes as you age, and what you can do about it.

Why Age Matters So Much

Shingles is caused by varicella-zoster virus, the same virus behind chickenpox. After a chickenpox infection resolves, the virus doesn’t leave your body. It retreats into nerve cells along the spinal cord and skull, where it can sit quietly for decades. The immune system keeps the virus in check through ongoing surveillance, but that surveillance weakens over time.

Research tracking immune responses across age groups has found that the body’s virus-specific immune defense starts declining meaningfully around age 40. At the same time, the amount of dormant virus lurking in nerve tissue begins increasing around age 50.¹ That combination, a weakening guard and a growing viral reservoir, is what makes the 50-and-older population increasingly vulnerable. It’s also why the risk doesn’t just nudge upward with age; it accelerates.

Shingles Risk at Every Stage of Life

By the time most people reach 40, nearly all of them have been infected with varicella-zoster virus, whether they remember having chickenpox or not. Seroprevalence studies put the figure around 95 to 97 percent by age 40.² That means virtually the entire adult population carries the virus and is theoretically at risk.

But “at risk” and “likely to get it” are very different things. A large nationwide study tracking shingles cases over more than a decade found that incidence rose sharply starting in the 50s, reaching about 13.5 per 1,000 person-years in that age group. The highest rates were in people aged 70 to 79, at roughly 17.2 per 1,000 person-years, closely followed by the 60-to-69 group at about 16.8.³ To put that in perspective, the lifetime chance of developing shingles is somewhere between 20 and 30 percent overall, but it climbs to roughly 50 percent by the time a person reaches 80.²

Younger adults in their 20s and 30s do get shingles, but it’s comparatively uncommon. When it does happen in this age group, it tends to be milder, resolve faster, and cause fewer long-term problems. The picture changes considerably after 50, and especially after 60, where both the likelihood of an episode and the severity of its consequences ramp up.

Can Children Get Shingles?

Yes, though it’s rare. A child who had chickenpox as a baby or toddler can develop shingles years later, sometimes while still in elementary school. And here’s something that surprises many parents: children who received the chickenpox vaccine rather than catching the disease naturally can also develop shingles, because the vaccine contains a live but weakened form of the virus that can establish latency in nerve cells just like wild-type infection does.

The good news is that shingles rates in vaccinated children are much lower than in unvaccinated children. A study comparing the two groups found that vaccinated children experienced shingles at a rate of 38 per 100,000 person-years, compared to 170 per 100,000 for unvaccinated children, a 78 percent difference.⁴ The weakened vaccine strain is less likely to reactivate than the wild virus. Still, the fact that it can happen at all means there’s no age at which shingles is impossible once the virus has entered the body.

Complications Get Worse With Age

Shingles at 25 is usually unpleasant but manageable: a band of painful blisters on one side of the torso, maybe some lingering sensitivity. Shingles at 75 is a different animal. The same rash can be the start of months or years of chronic pain, vision problems, or neurological damage. This divergence in outcomes is one of the most important age-related aspects of the disease.

Postherpetic Neuralgia

The most common complication is postherpetic neuralgia, a persistent nerve pain that lingers long after the rash has healed. It can last months or, in some cases, years, and it disproportionately hits older adults.⁵ The pain can be burning, stabbing, or a deep ache along the nerve path where the rash appeared, and for some people it’s severe enough to interfere with sleep, daily activities, and mood.

Research into how age shapes this risk has found that age is a significant predictor of postherpetic neuralgia, particularly in patients whose initial shingles pain was moderate to severe. In men, the risk increases in a straight line with age. In women, the relationship is more complex, with a peak in risk between ages 60 and 70.⁶ Either way, the older you are when shingles strikes, the more likely you are to deal with lasting pain afterward.

Eye Complications

When shingles affects the branch of the trigeminal nerve that serves the eye, it can cause inflammation of the cornea, retina, or optic nerve, sometimes leading to vision loss. A long-term study of shingles patients who developed eye complications found that the mean age at diagnosis was about 63, compared to a mean age of 52 for all shingles patients during the same period. Cases in people under 21 were extremely rare, with only five out of the entire study cohort.⁷ Being older than 60 is considered a major risk factor for this kind of involvement.⁸

Stroke Risk

A less well-known complication is the increased risk of stroke during and shortly after a shingles episode, likely because the virus can inflame blood vessels. One nationwide study found that shingles episodes were associated with a higher stroke risk overall, but the danger was particularly elevated in people aged 65 and older who were also taking common pain relievers (NSAIDs) during their episode, with an odds ratio of about 2.2.⁹ This doesn’t mean NSAIDs cause strokes in shingles patients, but it highlights how age compounds the vascular risks the virus creates.

Immune Suppression at Any Age

Age is the biggest single risk factor for shingles, but it’s not the only one. Anything that weakens the immune system can open the door to reactivation, regardless of how old you are. This is why shingles sometimes appears in otherwise healthy 30-year-olds who happen to be going through a period of severe immune stress.

The classic high-risk situations beyond aging include organ transplantation (the anti-rejection drugs suppress immunity), HIV infection, cancer treatment (chemotherapy and radiation both hammer the immune system), and long-term use of corticosteroids or other immunosuppressive medications.¹⁰ Chronic conditions like diabetes and cardiovascular disease also appear to raise risk, likely because they contribute to low-grade immune dysfunction over time.¹⁰

COVID-19 has added another wrinkle to this picture. Researchers have noted that SARS-CoV-2 infection can lower the immunological threshold needed to keep varicella-zoster virus in check, acting as a trigger for reactivation in people who might not have developed shingles otherwise.¹¹ This has led some clinicians to pay closer attention to shingles in younger adults, particularly those recovering from moderate or severe COVID illness.

When to Get Vaccinated

The shingles vaccine (Shingrix, the recombinant version now standard in most countries) is approved for adults 50 and older, and for younger adults who are immunocompromised. For the general healthy population, 50 is the threshold, even though shingles can technically happen earlier. The reasoning is straightforward: the risk-benefit equation tips decisively in favor of vaccination once you enter the age band where incidence starts climbing steeply. In adults 70 and older, Shingrix has been shown to reduce shingles over a mean follow-up of about 3.7 years.¹²

There’s no upper age limit for the vaccine. If you’re 85 and haven’t had it, it’s still recommended. The immune response may be somewhat weaker in the very old, but even a partial reduction in risk is valuable when the baseline risk is so high and the potential complications so serious. For younger immunocompromised individuals, the conversation should happen with their specialist, as the timing depends on their specific condition and treatment regimen.

Vaccine Coverage Gaps

Despite strong evidence for Shingrix’s effectiveness, uptake has been strikingly low. By 2020, only about one in seven Americans aged 50 and older reported having received the vaccine. And coverage wasn’t evenly distributed: it varied sharply by race, education, and income. White adults had coverage around 16.6 percent, compared to about 6.9 percent for Black adults and 6.3 percent for Hispanic adults. Adults with master’s degrees were vaccinated at roughly three and a half times the rate of those with less than a high school education. Household income showed a similar gradient, with coverage more than doubling between the lowest and highest income brackets.¹³

These gaps matter because the populations with the lowest vaccination rates often overlap with those carrying other risk factors for severe shingles, such as chronic disease and limited access to timely medical care. If you’re in the eligible age range and haven’t gotten Shingrix, cost and access may be barriers worth investigating. In the U.S., most insurance plans now cover the vaccine for adults 50 and older, though some plans require a copay, and the out-of-pocket cost without insurance can be substantial.

The Exogenous Boosting Question

There’s a genuinely interesting population-level puzzle playing out in the background of all this. For decades, adults living around young children with chickenpox may have received periodic “booster” exposures to the virus. Each time a grandparent or teacher encountered a child shedding varicella-zoster virus, their immune system got a reminder to keep its defenses up. This is called exogenous boosting, and some researchers have argued it’s one of the reasons shingles rates stayed lower in earlier generations.

A UK study using electronic health records found evidence that this effect is real: exposure to chickenpox cases did provide some protection against shingles. But the protection was partial, not the complete immunity that some earlier models had assumed.¹⁴ This matters because widespread childhood chickenpox vaccination, while dramatically reducing chickenpox itself, also reduces the number of children shedding the virus in the community. Fewer sick kids means fewer natural boosters for adults.

Modeling for England and Wales projected that universal chickenpox vaccination would cause a small, temporary rise in shingles cases, peaking about 22 years after introduction at 5 to 7 percent above pre-vaccination rates. After that hump, shingles incidence was projected to fall steadily, dropping 12 to 14 percent below pre-vaccination rates after 50 years, as the generations who never had wild-type chickenpox in the first place aged into adulthood with a weaker latent viral reservoir.¹⁵ In short, childhood chickenpox vaccination may cause a temporary bump in adult shingles before eventually reducing it for good. For today’s older adults, though, the bump is the relevant reality, which makes shingles vaccination all the more important for the current generation of 50-plus adults who grew up with wild-type chickenpox and may be losing their natural boosting opportunities.

What Shingles Actually Looks and Feels Like

Shingles typically begins with pain, tingling, or burning in a band-like area on one side of the body, usually the torso, though it can appear on the face, neck, or limbs. This prodromal pain phase often starts two to three days before any rash appears, which is one reason shingles gets misdiagnosed early on. People show up at the doctor complaining of what feels like a pulled muscle, a kidney stone, or even a heart attack, depending on where the nerve pain lands. Without a visible rash, the diagnosis isn’t obvious.

Once the rash does appear, it follows the path of a single nerve (a dermatome), forming a stripe of fluid-filled blisters that typically stays on one side of the body. The blisters crust over within a week or two. For most younger patients, that’s roughly the end of it. For older patients, the pain often persists well beyond the rash, and the severity of the initial episode tends to predict whether postherpetic neuralgia will follow.

Starting antiviral treatment within 72 hours of the rash appearing reduces the severity of the episode and lowers the risk of complications. This is one of the practical reasons to be aware of shingles symptoms even if you’re not in a high-risk age group: early recognition buys you a window to intervene.

Shingles Can Recur

A common misconception is that shingles is a one-time event, like chickenpox itself. It isn’t. The virus remains latent after a shingles episode and can reactivate again, sometimes more than once. Recurrence rates are higher in immunocompromised individuals, but even otherwise healthy people can have repeat episodes.¹⁰ Having had shingles once does not disqualify you from getting the vaccine; in fact, vaccination after a shingles episode is recommended to reduce the chance of recurrence.

The second episode can affect a different dermatome than the first, which sometimes catches people off guard. They assume they’re dealing with something new because the rash is in a different location. Recognizing the characteristic one-sided, band-like pattern remains the best clinical clue regardless of where on the body it shows up.

Stress, Sleep, and the Gray Area

You’ll often hear that stress triggers shingles. The relationship isn’t as clean as the popular narrative suggests, but there’s biological plausibility. Chronic psychological stress is known to suppress certain arms of the immune system, the same arms responsible for keeping varicella-zoster virus dormant. Physical stress matters too: major surgery, severe illness, or prolonged sleep deprivation can temporarily compromise immune surveillance in ways that give the virus an opening.

The challenge is that these triggers are hard to study rigorously. Most people who are stressed don’t get shingles, and many people who get shingles can’t point to an obvious stressor. What’s clearer is that stress probably isn’t sufficient on its own to cause reactivation in someone with a strong, young immune system, but it may be the tipping point in someone whose immunity is already declining for other reasons, age being the most common. If you’re in your 50s or 60s and going through a particularly rough stretch, it’s worth knowing that this is the kind of context where shingles can surface.